383 related articles for article (PubMed ID: 23611284)
1. Mechanisms of epigenetic regulation of leukemia onset and progression.
Ntziachristos P; Mullenders J; Trimarchi T; Aifantis I
Adv Immunol; 2013; 117():1-38. PubMed ID: 23611284
[TBL] [Abstract][Full Text] [Related]
2. MLL1/WDR5 complex in leukemogenesis and epigenetic regulation.
Wu M; Shu HB
Chin J Cancer; 2011 Apr; 30(4):240-6. PubMed ID: 21439245
[TBL] [Abstract][Full Text] [Related]
3. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
[TBL] [Abstract][Full Text] [Related]
4. Targeting epigenetic programs in MLL-rearranged leukemias.
Bernt KM; Armstrong SA
Hematology Am Soc Hematol Educ Program; 2011; 2011():354-60. PubMed ID: 22160057
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic modifiers in normal and malignant hematopoiesis.
Haladyna JN; Yamauchi T; Neff T; Bernt KM
Epigenomics; 2015; 7(2):301-20. PubMed ID: 25942537
[TBL] [Abstract][Full Text] [Related]
6. An Achilles' Heel for MLL-Rearranged Leukemias: Writers and Readers of H3 Lysine 36 Dimethylation.
Balbach ST; Orkin SH
Cancer Discov; 2016 Jul; 6(7):700-2. PubMed ID: 27371576
[TBL] [Abstract][Full Text] [Related]
7. A role for epigenetics in the formation of chromosome translocations in acute leukemia.
Gill Super HJ
Cancer Genet; 2015 May; 208(5):230-6. PubMed ID: 25953461
[TBL] [Abstract][Full Text] [Related]
8. The role of DOT1L in the maintenance of leukemia gene expression.
Wang X; Chen CW; Armstrong SA
Curr Opin Genet Dev; 2016 Feb; 36():68-72. PubMed ID: 27151433
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias.
Banday S; Farooq Z; Ganai SA; Altaf M
Clin Epigenetics; 2020 May; 12(1):73. PubMed ID: 32450905
[TBL] [Abstract][Full Text] [Related]
10. CpG island structure and trithorax/polycomb chromatin domains in human cells.
Orlando DA; Guenther MG; Frampton GM; Young RA
Genomics; 2012 Nov; 100(5):320-6. PubMed ID: 22819920
[TBL] [Abstract][Full Text] [Related]
11. In focus: MLL-rearranged leukemia.
de Boer J; Walf-Vorderwülbecke V; Williams O
Leukemia; 2013 Jun; 27(6):1224-8. PubMed ID: 23515098
[TBL] [Abstract][Full Text] [Related]
12. The language of chromatin modification in human cancers.
Zhao S; Allis CD; Wang GG
Nat Rev Cancer; 2021 Jul; 21(7):413-430. PubMed ID: 34002060
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics of Huntington's Disease.
Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M
Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552
[TBL] [Abstract][Full Text] [Related]
14. A role for DOT1L in MLL-rearranged leukemias.
Bernt KM; Armstrong SA
Epigenomics; 2011 Dec; 3(6):667-70. PubMed ID: 22126283
[No Abstract] [Full Text] [Related]
15. Disordered epigenetic regulation in MLL-related leukemia.
Zhang Y; Chen A; Yan XM; Huang G
Int J Hematol; 2012 Oct; 96(4):428-37. PubMed ID: 23054645
[TBL] [Abstract][Full Text] [Related]
16. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
[TBL] [Abstract][Full Text] [Related]
17. When epigenetics kills: MLL fusion proteins in leukemia.
Slany RK
Hematol Oncol; 2005 Mar; 23(1):1-9. PubMed ID: 16118769
[TBL] [Abstract][Full Text] [Related]
18. Recent progress toward epigenetic therapies: the example of mixed lineage leukemia.
Neff T; Armstrong SA
Blood; 2013 Jun; 121(24):4847-53. PubMed ID: 23649466
[TBL] [Abstract][Full Text] [Related]
19. Androgen-induced Epigenetic Profiles of Polycomb and Trithorax Genes in Prostate Cancer Cells.
Wang S; Tailor K; Kwabi-Addo B
Anticancer Res; 2020 May; 40(5):2559-2565. PubMed ID: 32366400
[TBL] [Abstract][Full Text] [Related]
20. The emerging roles of DOT1L in leukemia and normal development.
McLean CM; Karemaker ID; van Leeuwen F
Leukemia; 2014 Nov; 28(11):2131-8. PubMed ID: 24854991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]